Multisystem Inflammatory Syndrome (MIS-C) Clinical Pathway — Emergency, ICU and Inpatient

Antibiotics and Anti-Virals

Antibiotics

Antivirals

  • MIS-C is a post-infectious inflammatory process, not the direct result of the SARS-CoV-2 viral replication.
  • Antivirals are generally not indicated, even if the nasopharyngeal PCR test is positive.